Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-022-05766-0
Abstract: Fibroblast activation protein (FAP) and its inhibitors (FAPI) have attracted tremendous attention worldwide over the last several years [1–4]. A number of radiolabeled FAPI have been designed, synthesized, and evaluated in preclinical models, and many… read more here.
Keywords: cancer; tumor; medicine; albumin binding ... See more keywords
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients?
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of anticancer therapy"
DOI: 10.1080/14737140.2023.2213890
Abstract: INTRODUCTION To discuss the current evidence about radiolabeled-FAPI in patients affected by pancreatic cancer by underlying the advantages, disadvantages, and the future perspectives also in the theragnostic field. AREAS COVERED A literature search up until… read more here.
Keywords: cancer additional; radiolabeled fapi; pancreatic cancer; fapi pancreatic ... See more keywords